title: High-dose cytosine arabinoside for the treatment of acute myeloid leukemia. Studies of the North American Marrow Transplant Group.
authors.affiliation: Bone Marrow Transplantation Program, Vanderbilt University, Nashville, Tennessee 37232-4535.
authors.forename: S N
authors.initials: SN
authors.lastname: Wolff
authors.forename: R A
authors.initials: RA
authors.lastname: Brown
authors.forename: J W
authors.initials: JW
authors.lastname: Fay
authors.forename: G P
authors.initials: GP
authors.lastname: Herzig
authors.forename: R H
authors.initials: RH
authors.lastname: Herzig
authors.forename: G L
authors.initials: GL
authors.lastname: Phillips
mesh_terms: D003561:Cytarabine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*
chemical_list: D003561:Cytarabine